Assessment of De-Escalation to a Low Potency Single Antiplatelet Therapy Guided by Genetics vs High Potency Single Antiplatelet Therapy to Neutralize Bleeding After an Acute Coronary Syndrome
Condition: MYOCARDIAL INFARCTION Intervention: Other: single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by genetic testing. Sponsors: Assistance Publique - Hôpitaux de Paris; Fonds de Dotation ACTION Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2022 Category: Research Source Type: clinical trials
To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
Condition: Acute Coronary Syndrome Interventions: Drug: Rivaroxaban 2.5 Mg Oral Tablet; Drug: Clopidogrel tablet; Drug: Aspirin tablet Sponsors: Sarmad Zahoor; University of Managemant and Technology, Pakistan; Mayo Hospital Lahore Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2022 Category: Research Source Type: clinical trials
